BioPharma Dealmakers March 2016 edition

Our first edition of 2016 is now available. This spring issue explores the search for immuno-oncology combination therapies and includes a number of profiles from companies developing new technologies in the oncology field.

Like Comment

Read the March 2016 edition of BioPharma Dealmakers....

Read about the companies looking for partnerships from our March edition -

Andes Biotechnologies

InDanio BioSciences Inc.

ISA Pharma

MyCartis

OncoQuest Inc.

OncoSec

OncoTherapy Science

Synaffix

Read the in-depth partnering feature from our March edition -

Immuno-oncology dominates big pharma’s deal agenda

Go to the profile of Raveena Bhambra

Raveena Bhambra

Editor, BioPharma Dealmakers , Nature Research

Hello all, I am the Editor of BioPharma Dealmakers, a quarterly publication that assists companies in identifying potential partners in the pharmaceutical and biotechnology industry and appears in both Nature Biotechnology and Nature Reviews Drug Discovery. I am very passionate about the biopharma industry and have over 15 years of experience of working in the field, specifically in dealmaking, partnering and licensing. In my previous roles I have conducted partner searches identifying both products/technologies and partners for clients, and have edited and written dealmaking-focused reports.

No comments yet.